Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Italian Multiple Sclerosis Database Network.

M Trojano1, D Paolicelli, V Lepore

  • 1Department of Neurological and Psychiatric Sciences, University of Bari, Piazza Giulio Cesare 11, I-70124 Bari, Italy. mtrojano@neurol.uniba.it

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|September 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamics of domestic cat hepatitis B virus infection in juvenile cats.

Veterinary microbiology·2026
Same author

Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing.

Journal of the neurological sciences·2024
Same author

Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration.

Journal of neurology·2021
Same author

A multicenter survey on access to care in Multiple Sclerosis-related trigeminal neuralgia.

Journal of the neurological sciences·2021
Same author

Diagnosis, genetic characterization and clinical follow up of mitochondrial fatty acid oxidation disorders in the new era of expanded newborn screening: A single centre experience.

Molecular genetics and metabolism reports·2020
Same author

Informing MS patients on treatment options: a consensus on the process of consent taking.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2020
Same journal

Early and severe masticatory muscle involvement in SOD1-ALS: a case report with biomarker-clinical dissociation.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Early multimodal predictors of good neurological outcome in comatose patients after cardiac arrest: a prospective single-center cohort study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Telemedicine for headache disorders in real-world practice: from patient experience to health system impact.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Topography and functional connectivity analysis of heart surgery-associated brain lesions: a literature review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Limb apraxia in Parkinson's disease and atypical parkinsonian syndromes: a systematic review.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same journal

Primary Sjogren syndrome with suspected central nervous system inflammatory involvement.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
See all related articles

Long-term interferon beta (IFNbeta) treatment significantly reduces disability progression in multiple sclerosis (MS) patients. Early and sustained use of IFNbeta offers substantial benefits for managing MS long-term.

Area of Science:

  • Neurology
  • Immunology
  • Clinical Research

Background:

  • The Multiple Sclerosis Database Network (MSDN) is Italy's first MS registry.
  • Understanding long-term treatment effects is crucial for managing multiple sclerosis (MS).

Purpose of the Study:

  • To evaluate the long-term effectiveness of interferon beta (IFNbeta) on disability progression in MS patients.
  • To compare disability progression between patients with varying durations of IFNbeta exposure and untreated patients.

Main Methods:

  • Analysis of data from the MSDN cohort, including a sample of 2090 MS patients.
  • Comparison of disability progression (EDSS score change) in IFNbeta-treated versus untreated relapsing-remitting MS patients (subset of 1170 patients).

Main Results:

Related Experiment Videos

  • Patients exposed to IFNbeta for over 4 years showed a 4- to 5-fold reduced risk of disability progression compared to those exposed for up to 2 years.
  • IFNbeta-treated patients experienced a differential reduction in EDSS score change of -0.055 per year versus untreated patients.

Conclusions:

  • IFNbeta treatment demonstrates significant effectiveness in reducing long-term disability progression in multiple sclerosis.
  • Sustained use of IFNbeta is associated with better outcomes in managing MS-related disability.